Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epistaxis01:30

Epistaxis

172
Epistaxis, or nosebleeds, occurs when small, swollen blood vessels in the nasal mucous membrane rupture. Typically, the anterior septum is the primary site of occurrence.
Etiology
Possible causes of this condition include high blood pressure, trauma, low humidity, upper respiratory tract infections, allergies, foreign bodies, nasal inhalation of corticosteroids or illicit drugs, excessive use of decongestant nasal sprays, facial or nasal surgery, anatomic malformation, tumors, or systemic...
172

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hearing Outcomes Following Ventriculoperitoneal Shunt Placement: A Scoping Review.

Journal of clinical medicine·2026
Same author

Clinical outcomes and delayed proton therapy following endoscopic endonasal resection of large and giant pediatric craniopharyngiomas.

Neurosurgical focus·2026
Same author

Molecular Profiling of Olfactory Neuroblastoma Using the AACR Project GENIE Database.

Journal of neurological surgery. Part B, Skull base·2026
Same author

Comprehensive Genomic Profiling of Sinonasal Carcinomas: Identification of Common Mutations and Potential Targets for Therapy.

Journal of neurological surgery. Part B, Skull base·2026
Same author

Deciphering the Genomic Landscape of Oropharyngeal Squamous Cell Carcinoma: Distinct Mutation Patterns in Disease.

Life (Basel, Switzerland)·2026
Same author

Genomic Profiling of Laryngeal Squamous Cell Carcinoma Reveals Novel Biomarkers for Precision Medicine.

Journal of personalized medicine·2026
Same journal

Managing post-extubation dysphagia after prolonged intubation: A systematic review of Speech-Language Pathology (SLP) approaches.

American journal of otolaryngology·2026
Same journal

Rethinking indications for prophylactic central neck dissection in papillary thyroid microcarcinoma: A real-world retrospective study.

American journal of otolaryngology·2026
Same journal

Letter to the editor regarding "Development of a novel self-assessment tool following endoscopic sinus surgery in the management of chronic rhinosinusitis".

American journal of otolaryngology·2026
Same journal

Re: Sarcopenia and postoperative morbidity in head and neck cancer: a systematic review and meta-analysis.

American journal of otolaryngology·2026
Same journal

Epistaxis burden in hereditary hemorrhagic telangiectasia: Validation and refinement of the NOSE-HHT.

American journal of otolaryngology·2026
Same journal

An assessment of pharmacologic deep vein thrombosis prophylaxis on head and neck free flap outcomes.

American journal of otolaryngology·2026
See all related articles

Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury
07:17

Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury

Published on: March 22, 2024

1.1K

Nasal Epistaxis Balloons: A Comprehensive MAUDE Database Analysis.

Tyler B Merrill1, Christopher D Pool2, Robert A Saadi1

  • 1Department of Otolaryngology - Head and Neck Surgery, University of Arkansas for Medical Sciences, USA.

American Journal of Otolaryngology
|October 20, 2023
PubMed
Summary
This summary is machine-generated.

Nasal epistaxis balloons, while common, have associated risks. A review of adverse events revealed serious complications including death, device failure, and internal injuries, highlighting the need for increased provider and patient awareness.

Keywords:
Adverse eventEpistaxisMAUDE databaseNasal balloonPatient safetyRisk profile

More Related Videos

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

30.4K
Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation
11:03

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation

Published on: February 26, 2013

20.1K

Related Experiment Videos

Last Updated: Jul 12, 2025

Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury
07:17

Author Spotlight: A Novel Standardized Technique for Real-Time Biomedical Imaging of Acute Myocardial Injury

Published on: March 22, 2024

1.1K
Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples
11:54

Absorption of Nasal and Bronchial Fluids: Precision Sampling of the Human Respiratory Mucosa and Laboratory Processing of Samples

Published on: January 21, 2018

30.4K
Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation
11:03

Direct Pressure Monitoring Accurately Predicts Pulmonary Vein Occlusion During Cryoballoon Ablation

Published on: February 26, 2013

20.1K

Area of Science:

  • Otolaryngology
  • Medical Device Safety
  • Patient Outcomes

Background:

  • Nasal epistaxis balloons are widely used for nosebleed control.
  • The safety profile and complication rates of these devices are not well-established.

Purpose of the Study:

  • To analyze adverse events associated with nasal epistaxis balloons using the FDA MAUDE database.
  • To identify and categorize complications to improve clinical practice and patient counseling.

Main Methods:

  • Medical Device Reports (MDRs) for nasal epistaxis balloons were queried from the FDA MAUDE database.
  • Data from January 2012 to November 2022 were reviewed and categorized for device-related and patient-related events.

Main Results:

  • Out of 19 reports, 5 (26.3%) were device-related (e.g., leaks, breakage).
  • 14 reports (73.7%) were patient-related, including two deaths from exsanguination.
  • Other severe events included bowel perforation, CSF leak, intracranial placement, and respiratory distress.

Conclusions:

  • Nasal epistaxis balloons, despite general safety perception, have documented severe adverse events.
  • Awareness of these complications is crucial for informed consent and clinical decision-making.
  • Further investigation into device design and usage protocols may mitigate risks.